leo-15520
Small moleculeexperimental
Clinical trial activity
0 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Mechanism of action
- MAP kinase p38 alphaINHIBITOR
MAPK14 inhibitor
Thought to also inhibit MAPK11 and MAP2K6 but no further details available/found.
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL3545074 ↗
Also known as
- leo-15520